The emergence ofClostridium difficileas a pathogen of food animals
- 1 December 2004
- journal article
- review article
- Published by Cambridge University Press (CUP) in Animal Health Research Reviews
- Vol. 5 (2) , 321-326
- https://doi.org/10.1079/ahr200492
Abstract
Clostridium difficile causes pseudomembranous colitis in humans, usually after disruption of the bowel flora by antibiotic therapy. Factors mediating the frank disease include the dose and toxigenicity of the colonizing strain, its ability to adhere to colonic epithelium, the concurrent presence of organisms that affect multiplication and toxin production or activity, and the susceptibility of the host. Toxins A (an enterotoxin) and B (a cytotoxin) play the major role in pathogenesis and the detection of toxins in gut contents is the gold standard for diagnosis. Disease in horses takes the form of often-fatal foal hemorrhagic enteritis. Nosocomial, antibiotic-associated, disease is increasingly common in adult horses. Enteric clinical signs are reported in ostriches, companion animals and recently calves. Clostridium difficile colitis is now a common diagnosis in neonatal pigs in the USA and elsewhere. Clinical features include onset at 1–5 days of age, sometimes with dyspnea, mild abdominal distension and scrotal edema, and commonly with yellow, pasty diarrhea. There is mesocolonic edema grossly, with microscopic diffuse colitis, mucosal edema, crypt distension, epithelial necrosis and superficial mucosal erosion. Neutrophil infiltration of the lamina propria is common, and fibrin and numerous rod-shaped bacteria are observed on the surface. About two-thirds of litters and one-third of piglets will be affected (based upon positive toxin tests), although this appears to vary with the season. The case fatality rate is probably low if considering only direct effects of C. difficile infection. The significance of toxin-positive non-diarrheic pigs and the nature of the interaction of toxins A and B with enterocytes are unknown. Given the widespread occurrence of the disease, there is substantial effort to develop immunoprophylactic products.Keywords
This publication has 86 references indexed in Scilit:
- Acute Abdomen and Clostridium difficile Colitis: Still a Lethal CombinationDigestive Surgery, 2000
- Bovine immunoglobulin concentrate-Clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestineGut, 1999
- Clostridium difficile InfectionAnnual Review of Medicine, 1998
- Typhlocolitis Caused by Clostridium Difficile in Suckling PigletsJournal of Veterinary Diagnostic Investigation, 1998
- Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.Journal of Clinical Investigation, 1995
- Ten Years of Prospective Clostridium difficile-Associated Disease Surveillance and Treatment at the Minneapolis VA Medical Center, 1982-1991Infection Control & Hospital Epidemiology, 1994
- Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor bindingGastroenterology, 1992
- The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and nonimmune rabbitsJournal of Medical Microbiology, 1987
- PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITISThe Lancet, 1983
- Isolation of Clostridium difficile from pigsPublished by Wiley ,1983